Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.160
-0.200 (-4.59%)
Jul 28, 2026, 11:55 AM EDT - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $269.14 million as of July 28, 2026. Its market cap has increased by 84.21% in one year.
Market Cap
269.14M
Enterprise Value
75.52M
1-Year Change
84.21%
Ranking
Category
Stock Price
$4.16
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $269.14M, a decrease of -26.43%. That is a compound annual growth rate of -5.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 269.14M | -36.65% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 295.56M |
| OmniAb | 294.29M |
| Foghorn Therapeutics | 284.76M |
| Fate Therapeutics | 280.91M |
| Eledon Pharmaceuticals | 276.74M |
| Neumora Therapeutics | 276.07M |
| ALX Oncology Holdings | 273.16M |
| Bicycle Therapeutics | 270.17M |